Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · IEX Real-Time Price · USD
15.94
-0.02 (-0.13%)
At close: Apr 23, 2024, 4:00 PM
15.57
-0.37 (-2.32%)
After-hours: Apr 23, 2024, 4:38 PM EDT

Gyre Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Revenue
113.45102.297.3420.95001.020.41.751.81
Upgrade
Revenue Growth (YoY)
10.91%1293.98%-64.97%---155.14%-77.20%-3.47%246.65%
Upgrade
Cost of Revenue
4.644.797.389.16000000
Upgrade
Gross Profit
108.8197.5-0.0411.79001.020.41.751.81
Upgrade
Selling, General & Admin
75.8271.6118.9616.1813.4212.359.999.269.594.06
Upgrade
Research & Development
13.7816.6968.8952.9843.8621.4712.8511.565.965.27
Upgrade
Other Operating Expenses
86.44000000000
Upgrade
Operating Expenses
176.0488.2987.8569.1657.2833.8322.8420.8215.559.32
Upgrade
Operating Income
-67.239.2-87.89-57.37-57.28-33.83-21.82-20.42-13.8-7.51
Upgrade
Interest Expense / Income
000000001.480
Upgrade
Other Expense / Income
17.191.80.04-1.13-2.1-3.77-0.26-3.47-0.52-0.9
Upgrade
Pretax Income
-84.427.4-87.93-56.24-55.18-30.06-21.56-16.95-14.76-6.61
Upgrade
Income Tax
8.525.100000000
Upgrade
Net Income
-92.932.3-87.93-56.24-55.18-30.06-21.56-16.95-14.76-6.61
Upgrade
Preferred Dividends
0000003.95000
Upgrade
Net Income Common
-92.932.3-87.93-56.24-55.18-30.06-25.51-16.95-14.76-6.61
Upgrade
Shares Outstanding (Basic)
666421110000
Upgrade
Shares Outstanding (Diluted)
667621110000
Upgrade
Shares Change
-13.02%3605.16%59.76%59.77%7.05%227.52%339.43%163.88%1104.71%0.68%
Upgrade
EPS (Basic)
-1.410.04-43.05-43.95-69.00-40.20-111.75-326.25-749.85-4047.75
Upgrade
EPS (Diluted)
-1.410.03-43.05-43.95-69.00-40.20-111.75-326.25-749.85-4047.75
Upgrade
Free Cash Flow
18.045.69-84.59-55.32-43.68-28.93-19.96-18.05-19.39-6.29
Upgrade
Free Cash Flow Per Share
0.270.09-41.41-43.26-54.58-38.70-87.46-347.49-985.02-3850.73
Upgrade
Dividend Per Share
3.60021.450------8.535-
Upgrade
Dividend Growth
-83.22%---------
Upgrade
Gross Margin
95.91%95.31%-0.57%56.26%--100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-59.26%9.00%-1197.79%-273.87%---2143.61%-5117.29%-788.69%-414.18%
Upgrade
Profit Margin
-81.92%2.25%-1198.32%-268.48%---2506.09%-4246.87%-843.54%-364.75%
Upgrade
Free Cash Flow Margin
15.90%5.56%-1152.82%-264.06%---1961.00%-4523.81%-1108.00%-346.99%
Upgrade
Effective Tax Rate
-68.89%--------
Upgrade
EBITDA
-82.998.89-87.64-56.1-55.03-29.91-21.39-16.56-12.81-5.93
Upgrade
EBITDA Margin
-73.15%8.69%-1194.37%-267.82%---2100.98%-4149.37%-732.23%-327.25%
Upgrade
Depreciation & Amortization
1.431.490.290.140.150.150.170.390.470.68
Upgrade
EBIT
-84.427.4-87.93-56.24-55.18-30.06-21.56-16.95-13.28-6.61
Upgrade
EBIT Margin
-74.41%7.23%-1198.32%-268.48%---2117.98%-4246.87%-759.09%-364.75%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).